Chief Executive Officer
Ananda is Chief Executive Officer at MPE. She joined the team in March 2013.
She started getting involved in patient advocacy in 2007. Since then she has collaborated with a number of patient organisations across Europe. She has worked at the leading Institute of Public Law (IDP Barcelona) and the European Commission (DG Health and Consumers). Currently she is also Chair of the Workgroup of European Cancer Patient Advocacy Networks (WECAN) and a member of the Ethics Committee at the Chamber of Physicians of Bavaria, Germany.
She speaks Spanish, German, English, Catalan and French.
Ana joined the MPE team as Communications Manager in September 2016.
Ana worked as a journalist on weekly newspapers specialising in health and on consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communication department. Since 2014, Ana worked as PR and press consultant in the health department of an international PR agency developing communication strategies for the main pharmaceutical companies.
Ana has been involved in producing two books focused on patients with cancer as a co-writer and editorial co-ordinator. She speaks Spanish and English.
Kate is Policy and Public Affairs Manager at MPE. She joined the team in September 2017.
Kate previously worked for eight years in the Policy Team at Myeloma UK, where she was involved in influencing a range of policy and reimbursement decisions affecting myeloma patient access to good quality care and effective new drugs. She was involved in a number of patient and public advisory panels in the UK healthcare system, including for the Scottish Medicines Consortium, the drug approval body in Scotland.
She been involved in a wide-range of patient organisation networks, both nationally and internationally – most recently chairing the Blood Cancers Alliance, an information-sharing network of haematological cancer charities in the UK.
Kate currently lives and works in Edinburgh, Scotland.
Nicole joined MPE in March 2019 as Patient Advocacy Programme Manager.
Nicole has experience in health policy and communications research and health promotion programme evaluation in the areas of vaccination, tobacco control and addictions and mental health. Prior to working for MPE, she worked in Patient Advocacy in the pharmaceutical industry, driving capability building activities and initiatives to embed patient voice in pharmaceutical research and development.
Nicole is from Edmonton, Canada and has been living in Switzerland for over 8 years. She speaks English, French and German and is currently based in Zermatt, Switzerland.
Ingrid joined the MPE team as Finance and Reporting Officer in August 2018.
Ingrid has broad experience in large, medium-sized and start-up companies. She worked as referent and assistant to Executive Boards. In this role she was responsible, for board-, management- and finance-reporting and controlling. She has proficient expertise in project and programme management and implementation of administrative processes as well as in marketing and public relations.
In the health area she worked for the Innovative Medicines Initiative (IMI) project EUPATI. The European Patients’ Academy. This is a pan-European project implemented as a public-private partnership by a collaborative multi-stakeholder consortium from the pharmaceutical industry, academia, not-for-profit, and patient organisations. As Finance and Reporting Officer she supported the EUPATI Director in preparing reports for IMI and the international consortium members. Financial monitoring, control and analysis were part of her responsibility. Ingrid is based in Munich, Germany.
Michaela joined the MPE team in September 2018 to manage the AGM Secretariat.
Networking and bringing the right people together has always been a big motivator for her and she is in her element when organizing meetings and projects. She started getting involved in patient advocacy in 2001, first on a voluntary basis and since 2005 also on a professional basis. Since then she has collaborated with a number of patient organizations across Europe and supported them in the development and implementation of patient summits, conferences, Community Advisory Board meetings, Annual General Meetings, and Steering committee meetings.
Michaela speakes English and German and is based in Munich, Germany.